Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb
dc.rights.license | open | en_US |
hal.structure.identifier | Institut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA] | |
dc.contributor.author | MORGAT, Clement | |
dc.contributor.author | VAN DE VOORDE, Michiel | |
hal.structure.identifier | Institut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA] | |
dc.contributor.author | BODIN, Sacha | |
dc.contributor.author | CHAMPION, Christophe | |
hal.structure.identifier | Institut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA] | |
dc.contributor.author | HINDIE, Elif | |
dc.date.accessioned | 2024-06-17T10:08:01Z | |
dc.date.available | 2024-06-17T10:08:01Z | |
dc.date.issued | 2023-10-05 | |
dc.identifier.issn | 0928-1258 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/200490 | |
dc.description.abstractEn | 161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element are first described. Next, modeling studies, production, preclinical and clinical studies performed using 161Tb in prostate cancer are reviewed. | |
dc.description.sponsorship | Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003 | en_US |
dc.language.iso | EN | en_US |
dc.subject.en | Prostate cancer | |
dc.subject.en | Therapy | |
dc.title.en | Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb | |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1016/j.mednuc.2023.09.002 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
bordeaux.journal | Médecine Nucléaire | en_US |
bordeaux.page | 333-338 | en_US |
bordeaux.volume | 47 | en_US |
bordeaux.hal.laboratories | Institut de neurosciences cognitives et intégratives d'Aquitaine (INCIA) - UMR 5287 | en_US |
bordeaux.issue | 6 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | CNRS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-04614128 | |
hal.version | 1 | |
hal.date.transferred | 2024-06-17T10:08:03Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=M%C3%A9decine%20Nucl%C3%A9aire&rft.date=2023-10-05&rft.volume=47&rft.issue=6&rft.spage=333-338&rft.epage=333-338&rft.eissn=0928-1258&rft.issn=0928-1258&rft.au=MORGAT,%20Clement&VAN%20DE%20VOORDE,%20Michiel&BODIN,%20Sacha&CHAMPION,%20Christophe&HINDIE,%20Elif&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |